CD19 and neoplasm: Proven to be similarly effective in in vitro studies using various B-NHL cell lines as anti-CD19, CAR-37 L-H, and CAR H-L were studied in a xenogenic model of mantle cell lymphoma (MCL), where they showed similar efficacy in the eradication of tumor cells.